Concepedia

Fukushi Hirayama

FH

Statistics

Publications

27

Citations

734

H-Index

16

Active since

1989

Affiliations

Astellas Pharma (Japan)(Current)

Kyoto University

Fukushi Hirayama is an author at Astellas Pharma (Japan) specializing in pharmacology, medicinal chemistry, and drug discovery.

Publications per year

1989–2014

27

Publications

27

AKR‐501 (YM477) a novel orally‐active thrombopoietin receptor agonist

Mari Fukushima‐Shintani, Kenichi Suzuki, Yoshiyuki Iwatsuki et al. · European Journal Of Haematology · 2008 · 80 citations

, , +11

AKR-501 (YM477) in combination with thrombopoietin enhances human megakaryocytopoiesis

Mari Fukushima‐Shintani, Kenichi Suzuki, Yoshiyuki Iwatsuki et al. · Experimental Hematology · 2008 · 62 citations

, , +10

Antithrombotic effects of YM‐60828, a newly synthesized factor Xa inhibitor, in rat thrombosis models and its effects on bleeding time

Kazuo Sato, Tomihisa Kawasaki, Nami Hisamichi et al. · British Journal of Pharmacology · 1998 · 55 citations · Full text

, , +12

YM-60828, a novel factor Xa inhibitor: Separation of its antithrombotic effects from its prolongation of bleeding time

Kazuo Sato, Tomihisa Kawasaki, Yuta Taniuchi et al. · European Journal of Pharmacology · 1997 · 51 citations

, , +14

Comparative Studies of an Orally-active Factor Xa Inhibitor, YM-60828, with other Antithrombotic Agents in a Rat Model of Arterial Thrombosis

Kazuo Sato, Yumiko Sakai, Fukushi Hirayama et al. · Thrombosis and Haemostasis · 1998 · 41 citations

, , +17

1–5 of 27